A prospective controlled trial of oral kanamycin in the prevention of neonatal necrotizing enterocolitis.
D000284:Administration, Oral; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004761:Enterocolitis, Pseudomembranous / Q000517:prevention & control*; D004926:Escherichia coli; D005247:Feeding Behavior; D005431:Florida; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D007408:Intestinal Absorption; D007612:Kanamycin / Q000008:administration & dosage* / Q000097:blood; D011446:Prospective Studies
D007612:Kanamycin